Australia markets close in 5 hours 2 minutes

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1900-0.0100 (-5.00%)
At close: 04:00PM EDT
0.1980 +0.01 (+4.21%)
After hours: 07:46PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.12M
Enterprise value -15.58M
Trailing P/E 0.50
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.84
Price/book (mrq)0.24
Enterprise value/revenue -4.82
Enterprise value/EBITDA -1.28

Trading information

Stock price history

Beta (5Y monthly) 1.21
52-week change 3-69.23%
S&P500 52-week change 3-14.12%
52-week high 32.0900
52-week low 30.1900
50-day moving average 30.2486
200-day moving average 30.9108

Share statistics

Avg vol (3-month) 31.61M
Avg vol (10-day) 3352.81k
Shares outstanding 537.76M
Implied shares outstanding 6N/A
Float 822.62M
% held by insiders 128.20%
% held by institutions 113.58%
Shares short (14 Mar 2023) 4743.13k
Short ratio (14 Mar 2023) 40.3
Short % of float (14 Mar 2023) 41.98%
Short % of shares outstanding (14 Mar 2023) 41.97%
Shares short (prior month 14 Feb 2023) 4263.83k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.43
Trailing annual dividend yield 3715.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 311 Jan 2023
Ex-dividend date 412 Jan 2023
Last split factor 21:15
Last split date 312 Feb 2017

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 367.44%
Operating margin (ttm)-1,259.34%

Management effectiveness

Return on assets (ttm)-46.47%
Return on equity (ttm)26.37%

Income statement

Revenue (ttm)3.23M
Revenue per share (ttm)0.10
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-64.91M
EBITDA -40.39M
Net income avi to common (ttm)11.88M
Diluted EPS (ttm)0.3900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)23.09M
Total cash per share (mrq)0.73
Total debt (mrq)381k
Total debt/equity (mrq)1.30
Current ratio (mrq)18.40
Book value per share (mrq)0.93

Cash flow statement

Operating cash flow (ttm)-49.3M
Levered free cash flow (ttm)-35.22M